strains isolated from those countries where rifampicin is used for both tuberculous and non-tuberculous conditions ( italy , argentina , brazil , and spain ) did not show a higher incidence of primary resistance than did strains from other countries ( france , u.k. , and u.s.a. ) where rifampicin use is confined to tuberculosis .
C0035608
rifampicin
C0041296
tuberculosis